Plasma activated hydrogel therapy as a novel treatment for paediatric burns
Chief Investigator: Dr Ainslie Derrick-Roberts
Funding Amount : $99,946
Recipient: University of South Australia
Overview: Paediatric burns are common in children under the age of 5. Treatment of burns is complicated by life-threatening bacterial infections and scarring, which can lead to loss of limb function without surgical intervention. Plasma activated hydrogel therapy (PAHT) has potential to address all aspects of paediatric burns including infection control, healing promotion and reduced scarring. This study aims to optimise PAHT for treatment of paediatric burns through a rigorous preclinical trial, which will underpin a Human Ethics Application for Phase I trial. Early clinical applications of PAHT have the potential to save children’s lives and significantly improve their well-being.